Huge thanks to Dr. Dominik Witzigmann, PhD, and Dr. Wa'el Al Rawashdeh, Ph.D, EMBA for their inspiring talks on "Entrepreneurship and Innovation in Drug Delivery" in our Webinar Duet I: Careers in Industry on February 19.

Both speakers shared valuable insights on how to build and grow a career within the industry 👏

Join the CRS DeChAt Local Chapter for their 30th Annual Meeting held jointly with the 14th edition of the biennial Conference BioBarriers, taking place in Saarbrücken, March 3-6, 2026! Extended to three days, this year's program provides a vast portfolio of drug delivery technologies, new approach methods for drug development/ testing, and current trends in drug research.

We look forward to welcoming you! Visit: https://ow.ly/WxLY50XXkyQ to register and learn more.

The 1st CRS Ocular Delivery Focus Group (OcD FG) Online Symposium will bring together researchers from academia, industry, and clinical practice to discuss the latest advances in ocular drug delivery. The event will highlight innovative technologies and emerging therapeutic strategies aimed at overcoming the unique challenges of delivering drugs to the eye. Through invited presentations and selected abstracts, the symposium will provide a platform for knowledge exchange and collaboration within the global ocular drug delivery community.

This issue focuses on a reactive oxygen species (ROS)-responsive prodrug designed to tackle oxidative stress at its source – a key driver of corneal damage and tear film instability in DED.

🔎 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲
Dry eye disease remains difficult to treat effectively, as current therapies largely fail to address the underlying oxidative and apoptotic mechanisms responsible for disease progression.

⚗️ 𝗣𝗿𝗼𝗱𝗿𝘂𝗴 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆